Diclofenac Sodium Dual Release Pellets Manufacturer in India

Diclofenac Sodium Dual Release Pellets (CAS No: 15307-79-6)
Pharmaceutical-Grade Biphasic (Immediate + Sustained) Release Pellets for Oral Dosage Forms

Diclofenac Sodium Dual Release Pellets are pharmaceutical-grade multiparticulate pellets designed to deliver a biphasic drug-release profile — combining an immediate-release fraction for rapid onset with a sustained-release fraction for extended action, within a single capsule or tablet dosage form. This dual-release approach is commonly used to provide quicker analgesic/anti-inflammatory onset alongside a longer duration of action. Diclofenac Sodium has the molecular formula C₁₄H₁₀Cl₂NNaO₂ and a molecular weight of approximately 318.1 g/mol (source: PubChem).

A dual-release pellet system is typically formulated by blending two pellet populations — uncoated or minimally coated immediate-release pellets and polymer-coated sustained-release pellets — in a defined ratio, or by applying a partial functional coat to a single pellet population to achieve the combined release kinetics.

Key Features

• Biphasic (immediate + sustained) drug-release multiparticulate formulation
• Combines a fast-release fraction with an extended-release fraction in one dosage unit
• Suitable for pharmaceutical capsule filling and oral dosage-form development
• Flexible formulation platform for defined immediate:sustained release ratios
• Product-specific pellet size, drug loading and release-fraction ratio
• Appropriate for bulk pharmaceutical formulation applications

Applications

• Hard gelatin capsule filling for dual/biphasic-release oral dosage forms
• Multiparticulate oral dosage-form manufacturing
• Formulations requiring rapid onset plus extended duration of analgesic/anti-inflammatory action
• Pharmaceutical formulation development
• Bulk pharmaceutical pellet supply

Why Choose Diclofenac Sodium Dual Release Pellets?

• Biphasic multiparticulate platform for Diclofenac Sodium
• Designed for combined immediate + sustained drug-release requirements
• Suitable for capsule-based multiparticulate dosage forms
• Flexible drug loading and release-ratio options, subject to product specification
• Quality evaluation can include identification, assay/drug content, related substances, moisture, and two-stage/multi-point dissolution testing
• Available formulation characteristics can be established according to customer and product requirements

Packaging & Supply
Diclofenac Sodium Dual Release Pellets can be supplied in suitable pharmaceutical packaging for formulation development and bulk manufacturing applications. Packaging configuration, drug loading, release-fraction ratio, and storage requirements should be confirmed according to the applicable product specification and customer requirements.

Get Bulk Quote via WhatsApp